We previously reported that Medicines Australia submitted its 18th Edition of the Code of Conduct for approval by the ACCC.  

Subsequently, the Royal Australian College of General Practitioners reportedly alleged that, in doing so, Medicines Australia misled the ACCC by claiming the Code of Conduct was the result of broad consultation, when it differed significantly from its initial draft prepared by Medicines Australia’s Transparency Working Group, which was supported by the RACGP.  The RACGP claimed the final document clearly represents the pharmaceutical industry’s preferred position and has reportedly called on the ACCC to reject the Code of Conduct.  Medicines Australia has disputed the RACGP’s allegations.

To view the Code of Conduct, click here.

To view our previous Alert, click here.